Huxley Rachel, Barzi Federica, Woodward Mark
George Institute for International Health, University of Sydney, PO Box M201, Sydney, NSW 2050, Australia.
BMJ. 2006 Jan 14;332(7533):73-8. doi: 10.1136/bmj.38678.389583.7C. Epub 2005 Dec 21.
To estimate the relative risk for fatal coronary heart disease associated with diabetes in men and women.
Meta-analysis of prospective cohort studies.
Studies published between 1966 and March 2005, identified through Embase and Medline, using a combined text word and MESH heading search strategy, in addition to studies from the Asia Pacific Cohort Studies Collaboration.
Studies were eligible if they had reported estimates of the relative risk for fatal coronary heart disease comparing men and women with and without diabetes. Studies were excluded if the estimates were not adjusted at least for age.
37 studies of type 2 diabetes and fatal coronary heart disease among a total of 447,064 patients were identified. The rate of fatal coronary heart disease was higher in patients with diabetes than in those without (5.4 v 1.6%). The overall summary relative risk for fatal coronary heart disease in patients with diabetes compared with no diabetes was significantly greater among women than it was among men: 3.50, 95% confidence interval 2.70 to 4.53 v 2.06, 1.81 to 2.34. After exclusion of the eight studies that had adjusted only for age, the difference in risk between the sexes was substantially reduced but still highly significant. The pooled ratio of the relative risks (women: men) from the 29 studies with multiple adjusted estimates was 1.46 (1.14 to 1.88).
The relative risk for fatal coronary heart disease associated with diabetes is 50% higher in women than it is in men. This greater excess coronary risk may be explained by more adverse cardiovascular risk profiles among women with diabetes, combined with possible disparities in treatment that favour men.
评估男性和女性中与糖尿病相关的致死性冠心病的相对风险。
前瞻性队列研究的荟萃分析。
通过Embase和Medline检索1966年至2005年3月发表的研究,采用文本词和医学主题词联合检索策略,此外还纳入了亚太队列研究协作组的研究。
如果研究报告了比较患有和未患有糖尿病的男性和女性致死性冠心病相对风险的估计值,则该研究符合纳入标准。如果估计值未至少按年龄进行调整,则排除该研究。
共识别出37项关于2型糖尿病与致死性冠心病的研究,涉及447,064名患者。糖尿病患者的致死性冠心病发生率高于非糖尿病患者(5.4%对1.6%)。与无糖尿病者相比,糖尿病患者致死性冠心病的总体汇总相对风险在女性中显著高于男性:3.50,95%置信区间为2.70至4.53,而男性为2.06,1.81至2.34。排除仅按年龄调整的8项研究后,两性之间的风险差异大幅降低,但仍高度显著。29项进行了多项调整估计的研究中,相对风险的合并比值(女性:男性)为1.46(1.14至1.88)。
与糖尿病相关的致死性冠心病的相对风险在女性中比男性高50%。这种更高的冠心病额外风险可能是由于糖尿病女性中更不利的心血管风险状况,以及可能存在的有利于男性的治疗差异所致。